Principal Financial Group Inc. boosted its position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 6.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,357,823 shares of the health services provider's stock after purchasing an additional 147,032 shares during the quarter. Principal Financial Group Inc. owned about 1.82% of Select Medical worth $82,208,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of the business. GAMMA Investing LLC lifted its holdings in Select Medical by 16.6% in the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider's stock valued at $81,000 after buying an additional 330 shares during the period. Foster & Motley Inc. boosted its position in shares of Select Medical by 3.1% in the 2nd quarter. Foster & Motley Inc. now owns 12,147 shares of the health services provider's stock worth $426,000 after purchasing an additional 370 shares during the last quarter. KBC Group NV grew its stake in shares of Select Medical by 4.5% during the third quarter. KBC Group NV now owns 13,050 shares of the health services provider's stock worth $455,000 after purchasing an additional 563 shares during the period. Arizona State Retirement System increased its holdings in Select Medical by 2.0% in the second quarter. Arizona State Retirement System now owns 30,544 shares of the health services provider's stock valued at $1,071,000 after purchasing an additional 593 shares during the last quarter. Finally, Swiss National Bank lifted its stake in Select Medical by 0.4% in the third quarter. Swiss National Bank now owns 215,900 shares of the health services provider's stock valued at $7,528,000 after buying an additional 800 shares during the period. Institutional investors own 89.48% of the company's stock.
In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the business's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares of the company's stock, valued at $463,980. The trade was a 59.26 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company's stock, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by insiders.
NYSE:SEM opened at $19.06 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The business's 50-day simple moving average is $29.79 and its 200-day simple moving average is $33.23. Select Medical Holdings Co. has a fifty-two week low of $18.02 and a fifty-two week high of $40.98. The stock has a market capitalization of $2.47 billion, a PE ratio of 8.91, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43.
Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the firm posted $0.46 earnings per share. The business's revenue was up 5.7% on a year-over-year basis. Sell-side analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were issued a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.62%. Select Medical's dividend payout ratio (DPR) is 23.36%.
A number of analysts have recently commented on the company. Benchmark cut Select Medical from a "buy" rating to a "hold" rating in a research note on Monday, November 25th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, December 3rd. Finally, Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th.
View Our Latest Stock Analysis on SEM
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.